Regeneron Pharmaceuticals, Inc.
ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Abstract:

The present disclosure provides antibody-drug conjugates comprising anti-PTCRA antibodies and methods of using the same. The ADCs of the disclosure are useful for the treatment of T-ALL and other disorders related to elevated expression of PTCRA.